Ohcanbohtosat - Hemminki, Akseli
- Čájehuvvo 1 - 20 / 115
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
Oncolytic Immunotherapy: Where Are We Clinically? Dahkki Hemminki, Akseli
Almmustuhtton 2014Teaksta -
4
TILT Biotherapeutics Dahkki Hemminki, Akseli
Almmustuhtton 2017Teaksta -
5
Serotype Chimeric Human Adenoviruses for Cancer Gene Therapy Dahkki Ranki, Tuuli, Hemminki, Akseli
Almmustuhtton 2010Teaksta -
6
-
7
-
8
-
9
A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5 Δ24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemoth... Dahkki HAKKARAINEN, TANJA, HEMMINKI, AKSELI, CURIEL, DAVID T., WAHLFORS, JARMO
Almmustuhtton 2006Teaksta -
10
-
11
Patterns of metastasis in colon and rectal cancer Dahkki Riihimäki, Matias, Hemminki, Akseli, Sundquist, Jan, Hemminki, Kari
Almmustuhtton 2016Teaksta -
12
-
13
-
14
Oncolytic viruses for cancer immunotherapy Dahkki Hemminki, Otto, dos Santos, João Manuel, Hemminki, Akseli
Almmustuhtton 2020Teaksta -
15
-
16
-
17
Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer Dahkki Riihimäki, Matias, Thomsen, Hauke, Hemminki, Akseli, Sundquist, Kristina, Hemminki, Kari
Almmustuhtton 2013Teaksta -
18
-
19
-
20